Evidence map›Paper›PMID 38439594›Full record

ArticleCurrent protocols2024

Steady State and Time-Dependent Fluorescent Peptide Assays for Protein Kinases.

Rae M Sammons, Ashwini K Devkota, Tamer S Kaoud, Mangalika Warthaka, Eun Jeong Cho, Kevin N Dalby

Open access · greenAbstract read
In one paragraph

Article in Current protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rae M SammonsTargeted Therapeutic Drug Discovery and Development Program, The University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0000-0003-4211-0083
Ashwini K DevkotaTargeted Therapeutic Drug Discovery and Development Program, The University of Texas at Austin, Austin, Texas.
Tamer S KaoudTargeted Therapeutic Drug Discovery and Development Program, The University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0000-0003-1298-8725
Mangalika WarthakaTargeted Therapeutic Drug Discovery and Development Program, The University of Texas at Austin, Austin, Texas.
Eun Jeong ChoTargeted Therapeutic Drug Discovery and Development Program, The University of Texas at Austin, Austin, Texas.
Kevin N DalbyTargeted Therapeutic Drug Discovery and Development Program, The University of Texas at Austin, Austin, Texas.ORCID https://orcid.org/0000-0001-9272-5129
The University of Texas at Austin · US

Funding

Dual-Mechanism Allosteric Inhibitors of ERK SignalingR01CA262670 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI Kevin N Dalby · 2022 to 2026
$2.7M
Regulation of eEF-2K an Energy and Nutrient SensorR01GM123252 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI DALBY, KEVIN N, GHOSE, RANAJEET · 2017 to 2024
$2.7M
NCI NIH HHS R01 CA262670NIGMS NIH HHS R01 GM123252NIH HHS CA262670NIH HHS GM123252
6 · The paper itself

Abstract

Protein kinases catalyze the phosphorylation of proteins most commonly on Ser, Thr, and Tyr residues and regulate many cellular events in eukaryotic cells, such as cell cycle progression, transcription, metabolism, and apoptosis. Protein kinases each have a conserved ATP-binding site and one or more substrate-binding site(s) that exhibit recognition features for different protein substrates. By bringing ATP and a substrate into proximity, each protein kinase can transfer the γ phosphate of the ATP molecule to a hydroxyl group of the target residue on the substrate. In such a way, signaling pathways downstream from the substrate can be regulated based on the phosphorylated versus dephosphorylated status of the substrate. Although there are a number of ways to assay the activity of protein kinases, most of them are technically cumbersome and/or are indirect or based on quenched reactions. This protocol describes an assay employing a fluorescent peptide substrate to detect phosphorylation by protein kinases in real time. The assay is based on the principle that the phosphorylation of the peptide substrate leads to an increase in the fluorescence emission intensity of an appended fluorophore. We extend the application of this assay to an example of how to assess time-dependent covalent inhibition of kinases as well. © 2024 Wiley Periodicals LLC. Basic Protocol 1: Measuring protein kinase activity using fluorescent peptides Alternate Protocol: Measuring protein kinase activity using a fluorescence plate reader Support Protocol: Labeling peptides with sox fluorophore Basic Protocol 2: Measuring time-dependent ATP-competitive inhibition of protein kinases using fluorescent peptides.

Indexed as

PeptidesProtein KinasesAdenosine TriphosphateFluorescent DyesPhosphorylationAdenosine TriphosphateFluorescent DyesPeptidesProtein Kinasescovalent kinase inhibitionfluorescent peptideskinasespeptide assays

Identifiers

PMID38439594
PMCPMC10956166
OpenAlexW4392469481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.